Effect of soy isoflavones on the growth of human breast tumors. It is an oversimplification that isoflavones stimulate hormone-dependent tumor growth due to their potential estrogenic effect. Isoflavones may exert nonestrogenic anticancer effects. 2014-12-12

Isoflavones may help lower blood pressure. Daily consumption of soy products containing isoflavones could help to reduce the systolic blood pressure according to a study presented at the annual scientific session of the American College of Cardiology. 2012-04-23

Isoflavones reduce hot flashes. Soy isoflavones supplements are significantly more effective that placebo in reducing the severity and frequency of hot flashes, according to a new meta-analysis. 2012-04-20

Soy isoflavones increase bone mineral density. Chinese researchers found that soy isoflavones supplements increase bone mineral density, an important indirect indicator of osteoporosis , decrease urinary deoxypyridinoline, a reliable marker of bone resorption. 2012-03-01

Soy isoflavones reduce toxicity of radiation therapy. Prostate cancer patients showed reduced radiation toxicity in surrounding organs when treated with soy isoflavones. 2011-11-15

Isoflavones reduce prostate cancer risk. Although results of a new study indicate a protective effect of isoflavones against prostate cancer, we find it strange that such effect can be observed over a period of only one year, considering that the progression of prostate cancers is very slow. 2011-10-19

Soy isoflavones improve bone strength in postmenopausal women. A recent meta-analysis published in Maturitas concluded that soy isoflavones significantly increased the bone mineral density of the lumbar spine and moderately decreased urine deoxypyridinoline, a bone resorption marker. 2011-10-03

Soy isoflavones do not increase risk for breast cancer survivors. It may be beneficial to include soy foods as part of a healthy diet for women, including those which had breast cancer. Women with the highest intake of soy isoflavones had a 9 percent lower risk of mortality and a 15 percent lower risk of recurrence. 2011-04-10